NURS FPX 4025 Assessment 4 Presenting Your PICO(T) Process Findings to Your Professional Peers

Student Name

Capella University

NURS-FPX4025

Professor’s Name

Submission Date

Sharing Your PICO(T) Process Results with Your Colleagues

Good morning, my name is, and I am going to present to you an evidence-based plan which will prove to be helpful to patients with acute decompensated heart failure (ADHF), particularly those who could be at risk of having an ischemic stroke during their hospitalization. The concept of evidence-based practice (EBP) is extremely important in the work of nurses since EBP involves the application of clinical skills, personal preferences of the patient, as well as the most relevant research findings, which results in better patient outcomes. The application of the PICOT model in this scenario is a big assist, as it assists nurses in developing the appropriate questions about clinical practice. The aim of the given presentation is to elaborate on the diagnosis, formulate a PICOT question, locate the evidence concerning the topic in the academic literature, and outline key stages in EBP.

Diagnosis According to the Outcomes, Risks, and Complications

The ADHF is the extreme weakening of the power of the heart to convey sufficient portions of oxygenated blood in support of the metabolism of the organism. ADHF is linked to a large amount of fluid in the body, leading to congestion of the lungs and inadequate supply of blood to different body organs. According to a report by the Centers for Disease Control and Prevention (2024), almost 14.6% of deaths are caused by ADHF in adults aged 20 or older, resulting in 6.7 million adults with heart disease in the United States. Shortness of breath, weakness, leg edema, and poor tolerance to physical activity are the most prevalent symptoms of ADHF. ADHF is characterized by high morbidity and mortality rates and is considered one of the most urgent clinical issues that hospitalized patients have.

The presence of ADHF leads to long hospital stays, cardiac dysfunction, and low quality of life. The hemodynamic abnormalities, heart rhythm disorders including atrial fibrillation, clot formation, and end-organ perfusion dysfunction are some of the complications of ADHF (Milhem et al., 2025). One of the possible complications of ADHF, which is evident in practical situations, is ischemic stroke. It could also happen that the heart can develop blood clots, and the blood supply cannot reach the brain. Some of the complications that might arise as a result of ADHF include cardiogenic shock and respiratory failure as a result of pulmonary edema.

Examples

The problems of ADHF can be explained by a situation when a patient is admitted to the hospital due to a case of congestive heart failure and finds out that he is experiencing irregular heartbeats, which is known as atrial fibrillation. Atrial fibrillation also causes the accumulation of blood in the atrium of the heart. Thus, there is the possibility of the formation of blood clots. The clots of blood move to the brain, resulting in a stroke. Finally, the patient also acquires a neurological problem in the form of hemiplegia and aphasia. One more problem that can be identified with ADHF is evident when people experience fluid retention and decreased cardiac output, thereby resulting in hypoxemia due to pulmonary congestion.

PCIO(T) Question

In adult patients with acute decompensated heart failure (P), how does nurse-led early stroke risk assessment and prevention (I), compared to standard care with no risk assessment (C), influence the incidence of ischemic stroke (O) in the hospital (T)?

PICOT Breakdown

P (Population): adults with acute decompensated heart failure.
I (Intervention): Preventive risk assessment and intervention for stroke at an early age.
C (Comparison): Standard care in the absence of stroke risk assessment.
O (Outcome): Affect the occurrence of ischemic stroke
T (Time): During hospitalization (within 30 days)

Alignment with PICOT Framework

All the elements of the PICOT question apply to the particular clinical issue of ADHF. In relation to the first element, the population would be comprised of patients with ADHF who are at risk of developing thromboembolism. The intervention element entails the identification of the various risk factors that lead to stroke among patients. The comparisons would be between the status quo, where the risks have not been detected before the onset of stroke, and where the risk has been detected before the stroke has occurred. The outcome element would be geared towards ensuring that no ischemic stroke takes place, as this could be lethal.

Overview of Content of More Than Three Sources of Evidence

Multiple quality scientific papers have been reviewed to identify the effectiveness of early risk assessment of ischemic stroke in ADHF patients. In their research, Iguchi et al. (2021) carried out an observational study among more than 4,000 patients. They concluded that ischemic stroke is one of the main complications that occur during hospitalization for ADHF. The study found that BNP, atrial fibrillation, and acute coronary syndrome are significant predictors of a patient’s condition. Yamazaki et al. (2026), in turn, have conducted an observational study involving over 5,000 participants. They concluded that ischemic stroke occurs most often in the first 30 days of hospitalization and at the onset of the illness. Also, alterations in hemoglobin and the cardioembolic mechanism are factors believed to considerably increase the chance of having a stroke.

Ran et al. (2025) included 2,994 people and systematically reviewed and analyzed 11 clinical studies. The authors of this paper found NT-proBNP to be an excellent biomarker in assessing the patient’s outcome, including ischemic stroke. This article is extremely important because a number of sources are analyzed. Therefore, this research paper presents high-level evidence, and the role of biomarkers in assessing risks should be taken into account in medical practice. In Lucki et al. (2025), the study was an observational one that focused on the hospitalization outcomes of ADHF patients. The authors concluded that the more serious nature of the disease and long-term hospitalization are risk factors for additional complications, including thromboembolism. Even though the authors did not pay particular attention to stroke, the results are valuable for the prevention purposes of ADHF.

Credibility and Applicability of the Articles to a Diagnosis Problem

The chosen studies mentioned above may be considered valid given the fact that the selected studies have been published in peer-reviewed journal articles, as well as that the studies have used rigorous research methods when it comes to clinical studies. The systematic overview and meta-analysis by Ran et al. (2025) can be defined as the most plausible type of evidence since it sums up numerous studies and generalizable outcomes. Both the cohort studies mentioned by Iguchi et al. (2021) and Yamasaki et al. (2026) can be defined as very credible due to their large sample sizes and clinical relevance. The observational study presented by Lucki et al. (2025) is valid evidence for the prevention of heart failure.

Response to the PICO(T) Question on the basis of the Evidence Analysis

Based on the evidence, we can argue that early diagnosis and mitigation of the risks of having a stroke in the population of patients with acute decompensated heart failure are more beneficial than normal medical care. In particular, the research studies demonstrate strong evidence on the impact of high levels of biomarkers, such as BNP and NT-proBNP, to predict the likelihood of the occurrence of stroke and the necessity of early detection and prevention (Ran et al., 2025). Moreover, it is important to add that the highest risk of stroke can be observed in the first month of hospitalization. Finally, the results obtained during the analysis of the literature demonstrate that an organized risk assessment strategy makes it possible for clinicians to detect patients’ predisposition to stroke early (Lucki et al., 2025). In addition, it can prevent its development in the following ways: using anticoagulant medications and observing neurological indicators.

Determining Assumptions that the analysis is based on

There are some assumptions in this study. To begin with, it is assumed that the findings of the selected literature can be projected onto the larger population with heart failure (Wang et al., 2026). Second, it is assumed that the health care organizations possess the resources to do the tests on BNP and NT-proBNP to detect the risks at an early stage. Thirdly, it is presumed that the healthcare professionals will be able to perform any monitoring and prevention program as per the guidelines they will receive. Finally, the assumption is made that the patients will be monitored when they are within the hospital.

Evidence-based key steps of care

Several evidence-based interventions can be used to improve the care of patients with acute decompensated heart failure. To begin with, the risk factors of the patient immediately after admission also need to be estimated by determining the levels of biomarkers like BNP and NT-proBNP and the risk of atrial fibrillation (Ran et al., 2025). Such an intervention is important in order to detect those who need close observation.

Secondly, constant neuro-monitoring of the patient throughout the hospital stay is needed to detect an ischemic stroke as soon as possible and prevent any possible stroke complications (Yamazaki et al., 2026). Thirdly, pharmacological treatment and volume status management are needed in stroke prevention. Nonetheless, when necessary, anticoagulation is given. Fourthly, constant evaluation of a patient’s condition is necessary in order to detect changes in stroke risk factors (Iguchi et al., 2021). Finally, collaboration between multiple health professionals such as nurses, physicians, pharmacists, and other professionals is needed.

Reasoning why these are the best steps

These approaches are considered to be the most efficient as they deal with mechanisms leading to strokes in patients with ADHF. Screening enables one to establish whether a patient may be a victim of a thromboembolic event. Monitoring helps in detecting any signs of alteration in a patient’s brain condition (Milhem et al., 2025). Early identification of neurological changes allows healthcare professionals to initiate timely interventions and reduce the likelihood of severe stroke-related complications. Pharmacotherapy would prevent clotting and hence ensure the flow of blood. Re-assessment will enable an individual approach to a specific patient. An interdisciplinary approach assists in integrating various practices in medicine and, thus, removes the risk factor in the treatment process.

Conclusion

Acute decompensated heart failure is a severe and life-threatening disorder that may result in such complications as ischemic stroke, extended hospitalization, and death. As the analysis of the data provided in this assessment suggests, the clinical assessment and biomarkers used to assess stroke risk are significantly more effective compared to routine care in terms of patient outcomes improvement, as well as ischemic stroke prevention in inpatient care. In this respect, the PICOT framework can be incredibly helpful since this method assists nurses in formulating evidence-based clinical questions. Consequently, nurses’ skills to review the available literature and implement its results in clinical practice are enhanced.

References

Centers for Disease Control and Prevention. (2024). About heart failure. Centers for Disease Control and Prevention.gov. https://www.cdc.gov/heart-disease/about/heart-failure.html

Iguchi, M., Kato, T., Yaku, H., Morimoto, T., Inuzuka, Y., Tamaki, Y., Ozasa, N., Yamamoto, E., Yoshikawa, Y., Kitai, T., Hamatani, Y., Yamashita, Y., Masunaga, N., Ogawa, H., Ishii, M., An, Y., Taniguchi, R., Kato, M., Takahashi, M., & Jinnai, T. (2021). Ischemic stroke in acute decompensated heart failure: From the KCHF registry. Journal of the American Heart Association, 10(21). https://doi.org/10.1161/jaha.121.022525

Lucki, M., Mitkowski, P., Lucka, E., Grygier, M., Straburzyńska-Migaj, E., Morawiec, R., Kapłon-Cieślicka, A., Galas, A., Katarzyna Byczkowska, Hamala, P., Gorczyca-Głowacka, I., Furman-Niedziejko, A., Klimczak-Tomaniak, D., Major, A., Stefański, A., Guzik, M., Zachura, M., Staciwa, M., Pierzchała, E., & Nadel, M. (2025). Risk factors for prolonged hospitalization in acute decompensated heart failure from the HEROES study. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-14100-1

Milhem, F., Almur, O., Hajjeh, O., Bdair, M., Dahmas, A. M., Haddad, K. B., Shubietah, A., Al-Said, O. S., Al-Braik, R., Abukhalil, M. M., Ayaseh, Q. Z., Jallad, H., Karaki, L., Hamshari, H., & AbuBaha, M. (2025). Advances and controversies in acute decompensated heart failure treatment: Beta-blocker roles, emerging devices, and future directions. Annals of Medicine and Surgery, 87(9), 5696–5719. https://doi.org/10.1097/ms9.0000000000003592

Ran, J., Liu, Y., Ma, H., & Zhang, Y. (2025). Accuracy of NT-proBNP for predicting mortality amongst patients with ischemic stroke: A systematic review and meta-analysis. BMC Medicine, 23(1). https://doi.org/10.1186/s12916-025-04299-1

Wang, X., Wang, G., Liu, Y., Xia, L., Zhao, Y., Mao, L., Shi, X., & Yin, R. (2026). Effectiveness of symptom perception interventions among patients with heart failure: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1704096

Yamazaki, Y., Shiraishi, Y., Kohsaka, S., Ikegami, S., Kohno, T., Nagatomo, Y., Kitamura, M., Sakamoto, M., Nomoto, M., Takahashi, T., Kobayashi, M., Higuchi, S., Ieda, M., & Yoshikawa, T. (2026). Acute decompensated heart failure complicated by ischemic stroke and its association with hemoglobin levels. Circulation Reports, 12. https://doi.org/10.1253/circrep.cr-26-0015